Discovery and therapeutic promise of selective androgen receptor modulators

被引:101
作者
Chen, JY
Kim, J
Dalton, JT
机构
[1] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA
[2] GTx Inc, Memphis, TN 38163 USA
关键词
D O I
10.1124/mi.5.3.7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgens are essential for male development and the maintenance of male secondary characteristics, such as bone mass, muscle mass, body composition, and spermatogenesis. The main disadvantages of steroidal androgens are their undesirable physicochemical and pharmacokinetic properties. The recent discovery of nonsteroidal selective androgen receptor modulators (SARMs) provides a promising alternative for testosterone replacement therapies with advantages including oral bioavailability, flexibility of structural modification, androgen receptor specificity, tissue selectivity, and the lack of steroid-related side effects.
引用
收藏
页码:173 / 188
页数:16
相关论文
共 94 条
[1]   Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery [J].
Amory, JK ;
Chansky, HA ;
Chansky, KL ;
Camuso, MR ;
Hoey, CT ;
Anawalt, BD ;
Matsumoto, AM ;
Bremner, WJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (10) :1698-1701
[2]   Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study .3. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterones [J].
Anderson, RA ;
Wallace, AM ;
Wu, FCW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :902-908
[3]   Dihydrotestosterone and the prostate:: the scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia [J].
Andriole, G ;
Bruchovsky, N ;
Chung, LWK ;
Matsumoto, AM ;
Rittmaster, R ;
Roehrborn, C ;
Russell, D ;
Tindall, D .
JOURNAL OF UROLOGY, 2004, 172 (04) :1399-1403
[4]  
[Anonymous], 1990, Lancet, V336, P955
[5]  
[Anonymous], 2002, COCHRANE DB SYST REV
[6]  
Aribarg A, 1996, FERTIL STERIL, V65, P821
[7]   POTENTIAL OF TESTOSTERONE BUCICLATE FOR MALE CONTRACEPTION - ENDOCRINE DIFFERENCES BETWEEN RESPONDERS AND NONRESPONDERS [J].
BEHRE, HM ;
BAUS, S ;
KLIESCH, S ;
KECK, C ;
SIMONI, M ;
NIESCHLAG, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (08) :2394-2403
[8]  
Bhasin S, 2003, J GERONTOL A-BIOL, V58, P1002
[9]   Emerging issues in androgen replacement therapy [J].
Bhasin, S ;
Bremner, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :3-8
[10]   The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men [J].
Bhasin, S ;
Storer, TW ;
Berman, N ;
Callegari, C ;
Clevenger, B ;
Phillips, J ;
Bunnell, TJ ;
Tricker, R ;
Shirazi, A ;
Casaburi, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (01) :1-7